<DOC>
	<DOCNO>NCT00491413</DOCNO>
	<brief_summary>Erythropoietin ( Epo ) hormone normally find body may protect brain cell damage due lack oxygen . This study evaluate safety high-dose Epo infant get enough oxygen birth .</brief_summary>
	<brief_title>Erythropoietin Infants With Brain Injuries Due Oxygen Deprivation Birth</brief_title>
	<detailed_description>Damage central nervous system result oxygen deprivation birth major cause life-long mental developmental handicap . When enough oxygen blood ( hypoxemia ) brain deprive oxygen . Some brain cell respond produce Epo . Epo bind oxygen-deprived brain cell . This bind trigger chemical reaction within brain cell prevent cell death . Epo also reduce inflammation around brain cell act antioxidant . In animal study , recombinant Epo ( rEpo ) administration , even six hour oxygen deprivation , reduce subsequent brain injury 50 % 70 % . Epo use neonatologists stimulate erythropoiesis ( red blood cell production ) reduce incidence blood transfusion . Doses rEpo require protection brain cell considerably higher traditionally used neonatologists . This study evaluate pharmacokinetics , biologic effect , safety high dose Epo neonate brain injury due hypoxemia . Within six hour birth , eligible infant receive one dose rEpo intravenously . Any infant require lumbar puncture first week life level natural Epo rEpo spinal fluid measure . Blood test use measure antioxidant effect Epo impact red blood cell production . Neurodevelopmental outcome measure 6 12 month age .</detailed_description>
	<mesh_term>Asphyxia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Inclusion Criteria Infant 6 hour age less Apgar score less equal 3 1 5 minute Weight great 2500 gram ( 5.5 lb ) Central venous line place Exclusion Criteria infant ineligible meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>August 2003</verification_date>
	<keyword>neurodevelopmental outcome</keyword>
</DOC>